IgG has been the “default chassis” for therapeutic antibodies for decades—and for good reason: mature discovery workflows, predictable developability, well-characterized Fc effector biology, and scalable manufacturing. But the industry’s IgG-centric comfort zoneRead More…
Systemic lupus erythematosus (SLE) remains one of the most heterogeneous and diagnostically challenging autoimmune diseases. Its complex pathogenesis involves dysregulated B cell responses and the persistent production of pathogenic autoantibodies, often reflectedRead More…
Introduction Immunoglobulin A (IgA) antibodies are essential components of mucosal immunity, playing a crucial role in pathogen defense at the body’s surfaces, including respiratory and gastrointestinal tracts. With recent breakthroughs, IgA antibodiesRead More…